Follistatin 344

Preclinical Research

Follistatin 344

A naturally occurring protein that inhibits myostatin and activin. Muscle and fat effects come from mechanistic and animal research, not established human outcomes.

SubQ injectionIntramuscularMuscle GrowthBody Composition

Dose

100-200 mcg

Route

SubQ injection, Intramuscular

Cycle

4-8 weeks

Storage

Refrigerated (2-8°C) away from light. Can be stored at room temperature for short periods (up to a few weeks).

What is Follistatin 344?

Follistatin 344 is a naturally occurring glycoprotein that has garnered significant research interest for its potent ability to bind to and inhibit the activity of myostatin and activin. Myostatin is a protein that negatively regulates muscle growth, while activins are involved in various cellular processes including inflammation and fibrosis. By neutralizing these factors, Follistatin 344 is hypothesized to remove natural constraints on muscle hypertrophy and proliferation, leading to potential increases in muscle mass and reductions in adipose tissue. Research protocols often involve subcutaneous or intramuscular injection of the recombinant protein.

Key Benefits

  • Myostatin inhibition (mechanistic)
  • Muscle growth in animal models
  • Fat reduction in preclinical research

Mechanism of Action

  • Binds and inhibits myostatin and activin
  • Removes natural brake on muscle growth
  • Promotes muscle hypertrophy

Best For

  • Advanced muscle research
  • Myostatin inhibition research

Body Systems

MusculoskeletalEndocrine

๐Ÿพ Griffin Says...

Follistatin removes the brake on muscle growth. Myostatin normally limits how much muscle you can build, and follistatin inhibits it. Animal studies are dramatic. Human data is very limited. This is advanced territory that warrants serious caution.

Molecular Information

Molecular weight

37,700 Da (approximately for the mature, glycosylated form)

Length

344 amino acids

Type

Protein

Amino acid sequence

N/A (complex protein structure with multiple domains)

Follistatin 344 refers to the full-length human follistatin protein, which is a single-chain glycoprotein containing 344 amino acid residues.

Research Indications

  • Myostatin Inhibition

    Follistatin 344's primary research indication revolves around its ability to potently inhibit myostatin, a negative regulator of muscle growth. This mechanism is extensively studied for its potential to unlock significant muscle hypertrophy.

  • Muscle Proliferation and Differentiation

    Beyond myostatin inhibition, Follistatin 344 is also researched for its role in promoting the proliferation and differentiation of muscle cells (myogenesis), contributing to increased muscle fiber numbers and size.

Research Protocols

GoalDoseFrequencyRoute
Maximizing Muscle Hypertrophy100 mcgOnce dailySubcutaneous (SubQ) injection
Aggressive Muscle Mass Gain200 mcgOnce dailyIntramuscular (IM) injection
Targeted Muscle Growth (Localized effect theory)50-100 mcg per siteOnce daily (divided dose across multiple sites)Intramuscular (IM) into specific muscle groups
Extended Cycle for Sustained Gains50-75 mcgOnce dailySubcutaneous (SubQ) injection
Adjunctive Therapy for Muscle Wasting Conditions50-100 mcgEvery other daySubcutaneous (SubQ) injection

Timing protocols are commonly discussed in research to align with peak metabolic activity or post-workout recovery, although specific optimal timing remains a subject of ongoing investigation.

Peptide Interactions

  • IGF-1 (Insulin-like Growth Factor-1) variants (e.g., IGF-1 LR3, Mechano Growth Factor)

    Both compounds promote muscle growth through different pathways. Follistatin inhibits growth inhibitors, while IGF-1 directly stimulates growth. Research often explores their combined effects for enhanced anabolic outcomes.

    Synergistic
  • Growth Hormone Secretagogues (e.g., GHRP-2, GHRP-6, Ipamorelin, CJC-1295)

    These compounds increase natural growth hormone pulsatility, contributing to an overall anabolic environment that could complement Follistatin's muscle-building properties.

    Compatible
  • Testosterone and Anabolic Androgenic Steroids

    While both Follistatin and these compounds are highly anabolic, combining them could potentially amplify side effects or place additional stress on physiological systems. Close monitoring in research is essential.

    Monitor Combination
  • Insulin

    Insulin is a potent anabolic hormone. Combining with other strong anabolic agents like Follistatin may require careful dose management and metabolic monitoring to avoid adverse effects related to glucose regulation.

    Use Caution
  • Myostatin Inhibitors (other forms)

    As Follistatin 344 itself is a potent myostatin inhibitor, combining it with other compounds that share this primary mechanism may lead to redundant effects or unforeseen synergistic adverse reactions.

    Avoid

How to Reconstitute

  1. 1Gather supplies: Follistatin 344 vial, bacteriostatic water for injection, sterile syringe with needle (e.g., insulin syringe), alcohol wipes.
  2. 2Carefully remove the cap from the Follistatin 344 vial and wipe the rubber stopper with an alcohol wipe.
  3. 3Draw the desired amount of bacteriostatic water (e.g., 1-2 ml) into the sterile syringe. A common reconstitution ratio is 1ml of water per 1mg (1000mcg) of peptide.
  4. 4Slowly inject the bacteriostatic water into the Follistatin 344 vial, directing the stream down the side of the vial, not directly onto the lyophilized powder.
  5. 5Do not shake the vial. Gently swirl the vial between your fingers or roll it gently to allow the powder to dissolve completely. This may take several minutes.
  6. 6Once fully dissolved and clear, the solution is ready for administration. Store the reconstituted solution in the refrigerator.

Handle the lyophilized powder and reconstituted solution gently to avoid denaturing the protein. Use bacteriostatic water for reconstitution to extend shelf life.

What to Expect

  • Weeks 1-2: Initial observations may include mild increases in strength and recovery, though significant muscle changes are generally not yet prominent.
  • Weeks 3-4: Research suggests more noticeable improvements in muscle fullness, strength gains, and potentially a reduction in muscle soreness after training.
  • Weeks 5-6: Significant increases in muscle mass and strength are commonly reported in research discussions during this period, alongside potential body fat reduction.
  • Weeks 7-8: Peak effects are often observed, with continued muscle growth, improved body composition, and enhanced exercise performance.
  • Post-cycle: Maintenance of gains may depend on continued training and diet; some studies suggest a portion of muscle mass may be retained.
  • Throughout: Monitoring for any adverse effects and adjusting research parameters as needed is a common practice.

Side Effects & Safety

EffectFrequencySeverity
Injection site painCommonMild
Potential cardiovascular effects with excessive muscle massRareSerious

Ready to calculate your dose? Use Griffin's Peptide Calculator ๐Ÿพ

Open Calculator

Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.